As opposed to mirin and B02, pharmacological inhibitors of the DDR kinases ATM, ATR and DNA-PK were ineffective or mildly effective in sensitizing CRC-SCs to prexasertib (Figure 1A, Table S1). This evidence concerns the gene DDR1 and colorectal carcinoma.